| 注册
首页|期刊导航|四川医学|重组人甲状旁腺素(1-34)对绝经后骨质疏松症的治疗作用研究

重组人甲状旁腺素(1-34)对绝经后骨质疏松症的治疗作用研究

朱显军 张学军 李蓬秋 杨艳 张磊 鲜杨 吴冀川 包明晶

四川医学2011,Vol.32Issue(7):1020-1023,4.
四川医学2011,Vol.32Issue(7):1020-1023,4.

重组人甲状旁腺素(1-34)对绝经后骨质疏松症的治疗作用研究

Efficacy of recombinant human parathyroid hormone 1-34 (rhPTH1-34) in post-menopausal osteoporosis

朱显军 1张学军 1李蓬秋 1杨艳 1张磊 1鲜杨 1吴冀川 1包明晶1

作者信息

  • 1. 四川省人民医院内分泌科,四川成都610072
  • 折叠

摘要

Abstract

Objective To investigate the effect of rhPTH1-34 in treating post-menopausal osteoporosis. Methods 50 patients with post-menopausal osteoporosis were invided into 2 groups randomly and an open, controlled trial was conducted . The treating group included 37 patients ,they received rhPTH 1-34 20μ g/d, IH; The controlled group included 13 patients ,they received Calcitonin 20U/w, IM , all of them received Caltrate With Vitamin D600 Tablets 0. 6g/d, orally. This two groups were treated for 6 months. Results At base line ,this two groups showed no significant difference in ages, BMD of L1-4 , average BMD of lumbar, and trochanter of femur,but they showed significant difference in BMD of femoral neck and Ward's area. This two groups droped one patient respectively; By the end of the trial, BMD of L2 of the treating group increased more significantly than that of the controlled group( P < 0. 05 ), BMD of femoral neck increased less than that of the controlled group( P < 0. 05 ), BMD of Ward's area decreased , also less than that of the controlled group( P < 0. 05 ) , BMD of other sites showed no significant differences (P >0. 05 ); As for the treating group itself, BMD of L1 、L2 、L3 、L4 and average BMD of lumbar increased significantly( P < 0. 05 ), BMD of femoral neck and trochanter of femur increased,but not significantly(P > 0. 05) , BMD of Ward's area decreased , but also not significantly( P > 0. 05 ); As for the controlled group, BMD of L3 and average BMD of lumbar increased significantly( P < 0. 05 ),BMD of L1、 L2、L4、 femoral neck and Ward's area increased , but not significantly ( P > 0. 05 ), BMDof trochanter of femur decreased, but also not significantly( P > 0. 05 ) ;2 new fractures occurred in the treating group, one was fracture of the right humerus,the other was compressed fracture of lumbar; 1 new fracture of right fibula occurred in the controlled group; The insidence of side effects were similar in this two groups. Conclusion Efficacy of rhPTH1-34 was similar to that of Calcitonin in treating post-menopausal osteoporosis,and it's safe ,with light side effects .

关键词

重组人甲状旁腺素(1-34)/依降钙素/绝经后骨质疏松症

Key words

rhPTH1-34/ Calcitonin/ post-menopausal osteoporosis

分类

医药卫生

引用本文复制引用

朱显军,张学军,李蓬秋,杨艳,张磊,鲜杨,吴冀川,包明晶..重组人甲状旁腺素(1-34)对绝经后骨质疏松症的治疗作用研究[J].四川医学,2011,32(7):1020-1023,4.

四川医学

OACSTPCD

1004-0501

访问量1
|
下载量0
段落导航相关论文